ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Supported by Capital, the Application of mRNA Technology has Become a Hot Field in China
December 17, 2021In the middle of August, Abogen Biosciences announced that it had completed a third round of financing with its total amount exceeding 700 million US dollars, which set a new record for single financing before IPO of Chinese biopharmaceutical companies. -
GenScript ProBio, Abogen Biosciences and Walvax Biotechnology Enter into Collaboration on BLA and Commercial Manufacturing of mRNA Vaccine
November 30, 2021GenScript ProBio, Suzhou Abogen Biosciences Technology Co. ("Abogen Biosciences") and Walvax Biotechnology Co. ("Walvax Biotechnology") announced a collaboration on commercial manufacturing...
Pharma Sources Insight January 2025
